100398-25-2

Basic information

• Product Name: Benzene, 4-chloro-2-iodo-1-(phenylmethoxy)-
• CAS NO: 100398-25-2
• Molecular Formula: C13H10ClIO
• Molecular Weight: 344.579
• Mol File: 100398-25-2.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Benzene, 4-chloro-2-iodo-1-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 4-chloro-2-iodo-1-(phenylmethoxy)-(100398-25-2)
• EPA Substance Registry System: Benzene, 4-chloro-2-iodo-1-(phenylmethoxy)-(100398-25-2)

Safety Data

• Hazardous Substances Data: 100398-25-2(Hazardous Substances Data)

Upstream product

• 71643-66-8 4-chloro-2-iodo phenol 
• 106-48-9 4-chloro-phenol 
• 7700-27-8 4-chlorophenyl benzyl ether 
• 136808-72-5 2-iodo-5-chlorophenol 
• 100-39-0 benzyl bromide 
• 100-44-7 benzyl chloride 
• 142523-69-1 1-benzyloxy-2-iodobenzene 
• 52807-27-9 4-chloro-2-iodo-1-methoxybenzene 
• 6373-47-3 2-(benzyloxy)-5-chloroaniline 

Downstream Products

• 887495-80-9 3-[2-(2-benzyloxy-5-chloro-phenyl)-pyridin-3-yl]-benzoic acid ethyl ester 
• 850913-68-7 3-{3-[2-(benzyloxy)-5-chloro-phenyl]-pyridin-2-yl}-benzoic acid ethyl ester 
• 850913-66-5 3-{4-[2-(benzyloxy)-5-chloro-phenyl]-pyridin-3-yl}-benzoic acid ethyl ester 
• 612832-83-4 2-benzyloxy-5-chlorophenylboronic acid 
• 690261-31-5 ethyl 6-(5'-chloro-2'-hydroxy-2-biphenylyl)-2-pyridine-carboxylate 
• 690261-29-1 {5'-chloro-2'-[(phenylmethyl)-oxy]-2-biphenylyl}-boronic acid 
• 690259-69-9 5-(2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-yl)-1H-tetrazole 
• 690260-39-0 2-benzyloxy-5-chloro[1,1';2',1]terphenyl-3-carboxylic acid ethyl ester 
• 690259-49-5 (2-benzyloxy-5-chloro[1,1';2',1]terphenyl-3-yl) acetic acid 

Relevant articles and documents

Discovery of GSK345931A: An EP1 receptor antagonist with efficacy in preclinical models of inflammatory pain

Herein we describe the medicinal chemistry programme to identify a potential back-up compound to the EP1 receptor antagonist GW848687X. This work started with the lipophilic 1,2-biaryl benzene derivative 4 which displayed molecular weight of 41

PYRIDYL COMPOUNDS

Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein R1, R2, and R3 are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions compris

CYCLOHEXENE COMPOUNDS

Formula (I) wherein A, B, Z, R1, R2a , R2b, R8, R9 and Rx are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.